Excipients Market Size, Share & Analysis Report, 2022-2030
The global Excipients market size was estimated at USD 5.60 billion in 2021 and is expected to surpass around USD 9.57 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2022 to 2030.
Key Takeaways:
Increasing usage of generic medicines and rising demand for multifunctional excipients are expected to be the key factors driving revenue growth. Excipients have been recognized to provide better functionality and competitive advantage in drug formulations and this has contributed to their increased usage by pharmaceutical firms in recent years. Ongoing research and discovery of ideal or near-ideal substances that can be used in drug formulations and delivery have given the market a definite boost. Another factor contributing to global growth is that most pharmaceutical firms have been developing more sophisticated excipients with an enhanced role in drug delivery.
Globally increasing reach of generic medicines has been a major factor driving market growth. In addition, rising demand for newer excipients owing to the advantages of drug delivery and stability has led to the growth of the market.
Excipients are essential components for the improvement of overall pharmaceutical activity and performance, both of which directly impact the characteristics of pharmaceutical formulations. An excipient in the right proportion can improve the shelf life and bioavailability of a formulation. These can also be used in drug delivery mechanisms such as sustained release and rapid release drugs.
Polymers were the largest product category in 2021 based on revenue and volume and are expected to maintain a comparatively moderate growth rate over the forecast period. Microcrystalline cellulose was the leading polymer in this category, accounting for a share of over 26.0% in 2021.
Sugars are expected to observe the fastest growth over the coming years, exhibiting an estimated CAGR of 6.9% from 2022 to 2030. Sugars can play an instrumental role in increasing solubility, taste masking, dissolution, and drug delivery, which can drive its market.
The Market is significantly driven by the increasing demand for pharmaceutical products due to the COVID-10 virus outbreak. The development of the COVID-19 vaccine was one of the major drivers for this market growth. Many key organizations capitalized on the opportunities that arose during the pandemic and witnessed significant growth.
Report Scope of the Excipients Market
|
Report Coverage |
Details |
|
Market Size |
US$ 9.57 Billion by 2030 |
|
Growth Rate |
CAGR of 6.8% from 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Product and Region, |
|
Companies Mentioned |
Eastman Chemical Corporation; P&G Chemicals; Avantor Performance Materials, LLC; Huntsman Corporation; BASF SE; Ashland Inc.; FMC Corporation; Roquette; Colorcon Inc.; Lubrizol Corporation; Valeant; JRS Pharma; Shin-Etsu Chemical Co., Ltd.; DFE Pharma; Finar Limited |
Product Insights
Polymers, comprising microcrystalline cellulose and pregelatinized starch, emerged as the leading product category in terms of both revenue and volume. It accounted for over 44% of the total revenue in 2021 and almost 40% of the overall volume used in pharmaceutical formulations. Rising usage in various dosage forms such as suspensions, capsules, and tablets is anticipated to be a key driving factor for this segment in the forecast years.
Polymers can have multiple functions in drug development, which is attributed to their high usage in pharmaceutical R&D. They offer strength and improved shelf life when compared to other types of excipients used in pharmaceutical preparations. Polymers offer ideal formulation features for controlled/sustained release and help deliver drugs to specific target sites.
Sugars have emerged as the second-largest product segment, accounting for around 30% of the overall revenue in 2021. This can be attributed to their spherical shape and porous nature, which provides flowability and low friability, thereby making sugar a preferred choice in a wide range of pharmaceutical applications. Sugar is also used as a drug delivery agent through the pulmonary route and applications such as these are anticipated to fuel segment growth.
Regional Insights
Europe is closely followed by North America and Asia Pacific owing to the presence of larger companies, such as Avantor Performance Materials Inc. and FMC Corporation that are direct manufacturers of the products. The regions are expected to witness significant growth owing to ongoing case studies on drug-excipient interactions to enhance delivery efficiency and efficacy.
Asia Pacific and Middle East and Africa are expected to grow at a faster rate owing to an expanding generic market and high volume of unmet medical need in the regions. These regions also enable low-cost manufacturing processes and are a good source of raw material for manufacturing excipients.
Some of the prominent players in the Excipients Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Excipients market
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in Excipients Market Study:
Chapter 1. Research Methodology
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 Data Analysis
1.4 List of Primary & Secondary Sources
Chapter 2. Executive Summary
2.1 Market Snapshot
Chapter 3. Excipients Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Growing pharmaceutical market
3.1.1.2 Rising demand for novel excipients
3.1.1.3 Patent cliffs driving the growth of excipients in the generics market
3.1.2 Market restraint analysis
3.1.2.1 Stringent rules by regulatory bodies
3.2 Penetration & Growth Prospect Mappingfor Products, 2021
3.3 Excipients Market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
Chapter 4. Excipients Market: Product Estimates & Trend Analysis
4.1 Global Excipients Market: Product Movement Analysis
4.2 Polymers
4.2.1 Global polymers market, 2018 - 2030
4.2.2 Micro Crystalline Cellulose (MCC)
4.2.2.1 Global MCC market, 2018 - 2030
4.2.3 Hydroxy Propyl Methyl Cellulose (HPMC)
4.2.3.1 Global HPMC market, 2018 - 2030
4.2.4 Ethyl cellulose
4.2.4.1 Global ethyl cellulose market, 2018 - 2030
4.2.5 Methyl cellulose
4.2.5.1 Global methyl cellulose market, 2018 - 2030
4.2.6 Carboxy Methyl Cellulose (CMC)
4.2.6.1 Global CMC market, 2018 - 2030
4.2.7 Croscarmellose sodium
4.2.7.1 Global croscarmellose sodium market, 2018 - 2030
4.2.8 Povidone
4.2.8.1 Global povidone market, 2018 - 2030
4.2.9 Pregelatinized starch
4.2.9.1 Global pregelatinized starch market, 2018 - 2030
4.2.10 Sodium starch glycolate
4.2.10.1 Global sodium starch glycolate market, 2018 - 2030
4.2.11 Polyethylene glycol
4.2.11.1 Global polyethylene glycol market, 2018 - 2030
4.2.12 Acrylic polymers
4.2.12.1 Global acrylic polymers market, 2018 - 2030
4.3 Alcohol
4.3.1 Global alcohol market, 2018 - 2030
4.3.2 Glycerin
4.3.2.1 Global glycerin market, 2018 - 2030
4.3.3 Propylene glycol
4.3.3.1 Global propylene glycol market, 2018 - 2030
4.3.4 Sorbitol
4.3.4.1 Global sorbitol market, 2018 - 2030
4.3.5 Mannitol
4.3.5.1 Global mannitol market, 2018 - 2030
4.3.6 Others
4.3.6.1 Global other alcohol market, 2018 - 2030
4.4 Minerals
4.4.1 Global minerals market, 2018 - 2030
4.4.2 Calcium phosphate
4.4.2.1 Global calcium phosphate market, 2018 - 2030
4.4.3 Calcium carbonate
4.4.3.1 Global calcium carbonate market, 2018 - 2030
4.4.4 Clay
4.4.4.1 Global clay market, 2018 - 2030
4.4.5 Silicon dioxide
4.4.5.1 Global silicon dioxide market, 2018 - 2030
4.4.6 Titanium dioxide
4.4.6.1 Global titanium dioxide market, 2018 - 2030
4.4.7 Others
4.4.7.1 Global other minerals market, 2018 - 2030
4.5 Sugar
4.5.1 Global sugar market, 2018 - 2030
4.5.2 Lactose
4.5.2.1 Global lactose market, 2018 - 2030
4.5.3 Sucrose
4.5.3.1 Global sucrose market, 2018 - 2030
4.5.4 Others
4.5.4.1 Global other excipients market, 2018 - 2030
4.6 Gelatin
4.6.1 Global gelatin market, 2018 - 2030
Chapter 5. Market Categorization: Regional Estimates & Trend Analysis, by Product
5.1 Global Excipients Market: Region Movement Analysis
5.2 North America
5.2.1 North America excipients market, 2018 - 2030
5.2.2 U.S.
5.2.2.1 U.S. excipients market, 2018 - 2030
5.2.3 Canada
5.2.3.1 Canada excipients market, 2018 - 2030
5.3 Europe
5.3.1 Europe excipients market, 2018 - 2030
5.3.2 Germany
5.3.2.1 Germany excipients market, 2018 - 2030
5.4 Asia Pacific
5.4.1 Asia Pacific excipients market, 2018 - 2030
5.4.2 Japan
5.4.2.1 Japan excipients market, 2018 - 2030
5.5 Latin America
5.5.1 Latin America excipients market, 2018 - 2030
5.5.2 Brazil
5.5.2.1 Brazil excipients market, 2018 - 2030
5.6 Middle East & Africa (MEA)
5.6.1 Middle East & Africa excipients market, 2018 - 2030
5.6.2 South Africa
5.6.2.1 South Africa excipients market, 2018 - 2030
Chapter 6. Competitive Landscape
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Eastman Chemical Corporation
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.2 P&G
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.3 Avantor Performance Materials, LLC
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Huntsman Corporation
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 BASF SE
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 Ashland Inc.
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 FMC Corporation
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 Roquette
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
6.3.9 Colorcon Inc.
6.3.9.1 Company overview
6.3.9.2 Financial performance
6.3.9.3 Product benchmarking
6.3.9.4 Strategic initiatives
6.3.10 Lubrizol Corporation
6.3.10.1 Company overview
6.3.10.2 Financial performance
6.3.10.3 Product benchmarking
6.3.10.4 Strategic initiatives
6.3.11 Valeant
6.3.11.1 Company overview
6.3.11.1.1 The Dow Chemical Company (Dow Pharma Solutions)
6.3.11.2 Financial performance
6.3.11.2.1 Financial performance
6.3.11.3 Product benchmarking
6.3.12 JRS PHARMA
6.3.12.1 Company overview
6.3.12.2 Financial performance
6.3.12.3 Product benchmarking
6.3.12.4 Strategic initiatives
6.3.13 Shin-Etsu Chemical Co., Ltd
6.3.13.1 Company overview
6.3.13.1.1 SE Pharma & Food Materials Distribution GmbH
6.3.13.2 Financial performance
6.3.13.3 Product benchmarking
6.3.13.4 Strategic initiatives
6.3.14 DFE pharma
6.3.14.1 Company overview
6.3.14.2 Financial performance
6.3.14.3 Product benchmarking
6.3.14.4 Strategic initiatives
6.3.15 FINAR LIMITED
6.3.15.1 Company overview
6.3.15.2 Financial performance
6.3.15.3 Product benchmarking
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers